Source:http://linkedlifedata.com/resource/pubmed/id/11679924
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
2001-10-26
|
pubmed:abstractText |
Prednisolone slows the loss of CD4 T cells in individuals with human immunodeficiency virus (HIV) disease and inhibits antigen-induced apoptosis of recently HIV-infected CD4 cells in vitro. This study investigated whether dexamethasone inhibits the ability of macrophages to delete CD4 T cells via anti-CD4 antibody or immune-complexed HIV envelope protein gp120. Peripheral blood mononuclear cells from HIV-negative persons were incubated with CD4-reactive ch412 monoclonal antibody or with gp120/IgG immune complexes and resident macrophages, with and without dexamethasone. Dexamethasone inhibited CD4 cell deletion in a dose-dependent manner. The deletion of normal CD4 cells by macrophages from HIV-infected patients also was inhibited by dexamethasone. Furthermore, up-regulation of CD95 expression on T cells exposed to anti-CD4 and gp120/IgG, which predisposes T cells to CD95-mediated apoptosis, is inhibited by dexamethasone in a dose-dependent fashion. Dexamethasone inhibits the macrophage-mediated deletion of CD4 lymphocytes in HIV-infected persons.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD95,
http://linkedlifedata.com/resource/pubmed/chemical/Dexamethasone,
http://linkedlifedata.com/resource/pubmed/chemical/Glucocorticoids,
http://linkedlifedata.com/resource/pubmed/chemical/HIV Envelope Protein gp120
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0022-1899
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
184
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1328-30
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:11679924-Adult,
pubmed-meshheading:11679924-Antibodies, Monoclonal,
pubmed-meshheading:11679924-Antibody-Dependent Cell Cytotoxicity,
pubmed-meshheading:11679924-Antigens, CD95,
pubmed-meshheading:11679924-CD4-Positive T-Lymphocytes,
pubmed-meshheading:11679924-Dexamethasone,
pubmed-meshheading:11679924-Dose-Response Relationship, Immunologic,
pubmed-meshheading:11679924-Glucocorticoids,
pubmed-meshheading:11679924-HIV Envelope Protein gp120,
pubmed-meshheading:11679924-HIV Infections,
pubmed-meshheading:11679924-HIV-1,
pubmed-meshheading:11679924-Humans,
pubmed-meshheading:11679924-Macrophages,
pubmed-meshheading:11679924-Up-Regulation
|
pubmed:year |
2001
|
pubmed:articleTitle |
Dexamethasone inhibits CD4 T cell deletion mediated by macrophages from human immunodeficiency virus-infected persons.
|
pubmed:affiliation |
Department of Microbiology and Immunology, Division of Infectious Diseases, New York Medical College, Valhalla, New York, USA. thorsten.orlikowski@med.uni-tuebingen.de
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|